127 related articles for article (PubMed ID: 12374900)
1. Assessment of quality of life in a double-blind, randomized clinical trial of imidapril and captopril for hypertensive Chinese in Taiwan.
Chien KL; Huang PJ; Chen MF; Chiang FT; Lai LP; Lee YT
Cardiovasc Drugs Ther; 2002 May; 16(3):221-6. PubMed ID: 12374900
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of imidapril in patients with essential hypertension: a double-blind comparison with captopril.
Huang PJ; Chien KL; Chen MF; Lai LP; Chiang FT
Cardiology; 2001; 95(3):146-50. PubMed ID: 11474160
[TBL] [Abstract][Full Text] [Related]
3. Cough-challenge trial with a new angiotensin-converting enzyme inhibitor, imidapril.
Shionoiri H; Takasaki I; Minamisawa K; Ueda S; Kihara M; Shindo K; Hiroto S; Sugimoto K; Himeno H; Naruse M; Nagamochi I; Yasuda G
J Clin Pharmacol; 1998 May; 38(5):442-6. PubMed ID: 9602958
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, parallel-group study to compare the anti-hypertensive effects of imidapril and nifedipine in the treatment of mild-to-moderate essential hypertension.
van der Does R; Euler R
J Int Med Res; 2001; 29(3):154-62. PubMed ID: 11471852
[TBL] [Abstract][Full Text] [Related]
5. Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM).
Katayama S; Kikkawa R; Isogai S; Sasaki N; Matsuura N; Tajima N; Urakami T; Uchigata Y; Ohashi Y
Diabetes Res Clin Pract; 2002 Feb; 55(2):113-21. PubMed ID: 11796177
[TBL] [Abstract][Full Text] [Related]
6. A 24-week dose-titration study of the angiotensin-converting enzyme inhibitor imidapril in the treatment of mild-to-moderate essential hypertension in the elderly.
Dews I; VandenBurg M
J Int Med Res; 2001; 29(2):100-7. PubMed ID: 11393342
[TBL] [Abstract][Full Text] [Related]
7. [Efficiency and safety of ACE-inhibiting imidapril in patients with essential hypertension].
Zweiker R; Stoschitzky K; Maier R; Klein W
Acta Med Austriaca; 2002; 29(2):72-6. PubMed ID: 12050950
[TBL] [Abstract][Full Text] [Related]
8. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
Katoh M; Ohmachi Y; Kurosawa Y; Yoneda H; Tanaka N; Narita H
Eur J Pharmacol; 2000 Jun; 398(3):381-7. PubMed ID: 10862828
[TBL] [Abstract][Full Text] [Related]
9. Dose finding studies with imidapril--a new ACE inhibitor.
Vandenburg MJ; Mackay EM; Dews I; Pullan T; Brugier S
Br J Clin Pharmacol; 1994 Mar; 37(3):265-72. PubMed ID: 8198936
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.
Yodfat Y; Bar-On D; Amir M; Cristal N
J Hum Hypertens; 1996 Feb; 10(2):117-22. PubMed ID: 8867566
[TBL] [Abstract][Full Text] [Related]
11. Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
Amir M; Cristal N; Bar-On D; Loidl A
Blood Press Suppl; 1994; 1():40-2. PubMed ID: 8205297
[TBL] [Abstract][Full Text] [Related]
12. Quality of life of patients with mild hypertension treated with captopril: a randomized double-blind placebo-controlled clinical trial.
Hu Y; Zhu J
Chin Med J (Engl); 1999 Apr; 112(4):302-7. PubMed ID: 11593526
[TBL] [Abstract][Full Text] [Related]
13. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
[TBL] [Abstract][Full Text] [Related]
14. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.
Hosoya K; Ishimitsu T
Cardiovasc Drug Rev; 2002; 20(2):93-110. PubMed ID: 12177688
[TBL] [Abstract][Full Text] [Related]
15. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control.
Saruta T; Omae T; Kuramochi M; Iimura O; Yoshinaga K; Abe K; Ishii M; Watanabe T; Takeda T; Ito K
J Hypertens Suppl; 1995 Sep; 13(3):523-30. PubMed ID: 8592249
[TBL] [Abstract][Full Text] [Related]
16. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group.
Testa MA; Anderson RB; Nackley JF; Hollenberg NK
N Engl J Med; 1993 Apr; 328(13):907-13. PubMed ID: 8446137
[TBL] [Abstract][Full Text] [Related]
18. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
[TBL] [Abstract][Full Text] [Related]
19. High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.
van Veldhuisen DJ; Genth-Zotz S; Brouwer J; Boomsma F; Netzer T; Man In 'T Veld AJ; Pinto YM; Lie KI; Crijns HJ
J Am Coll Cardiol; 1998 Dec; 32(7):1811-8. PubMed ID: 9857856
[TBL] [Abstract][Full Text] [Related]
20. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
Paran E; Anson O; Neumann L
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
